In a retrospective study of 229 patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy regimens, we show that patients who experienced an infusion reaction had a higher probability of survival compared with those who did not.
- Diffuse large B-cell lymphoma
- Infusion reaction
ASJC Scopus subject areas
- Cancer Research